title: Natural-killer cell activity and cytogenetic response in chronic myelogenous leukemia treated with alpha-interferon.
authors.forename: A
authors.initials: A
authors.lastname: Meseri
authors.forename: V
authors.initials: V
authors.lastname: Delwail
authors.forename: F X
authors.initials: FX
authors.lastname: Mahon
authors.forename: D
authors.initials: D
authors.lastname: Pelletier
authors.forename: F
authors.initials: F
authors.lastname: Guilhot
authors.forename: A
authors.initials: A
authors.lastname: Brizard
authors.forename: J
authors.initials: J
authors.lastname: Gombert
authors.forename: J
authors.initials: J
authors.lastname: Tanzer
authors.forename: P
authors.initials: P
authors.lastname: Goube de Laforest
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002675:Child, Preschool; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins